Hester Biosciences Ltd Q1FY23 consolidated net profit lower at Rs. 3.56 crores

Hester Biosciences Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 53.818 crores during the period ended June 30, 2022 as compared to Rs. 63.661 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 3.56 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 9.007 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 4.19 for the period ended June 30, 2022 as compared to Rs. 10.59 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹53.818 crs	₹63.661 crs	-15.46%
Net Profit	₹3.56 crs	₹9.007 crs	-60.48%
EPS	₹4.19	₹10.59	-60.43%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs.53.818 crores during the period ended June 30, 2022 as compared to Rs.62.534 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.3.56 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.11.019 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.4.19 for the period ended June 30, 2022 as compared to Rs.12.95 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹53.818 crs	₹62.534 crs	-13.94%
Net Profit	₹3.56 crs	₹11.019 crs	-67.69%
EPS	₹4.19	₹12.95	-67.64%

Shares of Hester Biosciences Limited was last trading in BSE at Rs. 2412.10 as compared to the previous close of Rs. 2390.65. The total number of shares traded during the day was 62 in over 13 trades.

The stock hit an intraday high of Rs. 2421.35 and intraday low of 2385.85. The net turnover during the day was Rs. 149550.00.

Source : Equity Bulls

Keywords

HesterBiosciences Q1FY23 ResultUpdate